PTC THERAPEUTICS, INC. — Form 4
Filed August 21, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 44/100
What the filing says
Director SCHMERTZLER MICHAEL (PTCT) sold 25K shares (~$1.8M) on the open market (1.8% of holdings). Open-market sale — often routine.
Why this rating
Open-market sale — often routine.
See more from August 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.